On March 9, 2022 Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, reported that management will present at the following upcoming investor conferences (Press release, Alector, MAR 9, 2022, View Source [SID1234609786]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Barclays Global Healthcare Conference (Miami, Florida)
Wednesday, March 16, 2022 at 3:20 p.m. ET, Fireside Chat
Stifel CNS Days (Virtual)
Monday, March 28, 2022 at 11:30 a.m. ET, Corporate Presentation
Live webcasts of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the Alector website at View Source Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.